DIOSMIN/HESPERIDIN 500 MG 30 TABLETS DAFLON VASOPROTECTIVE and VENOTONIC
DAFLON 500 MG FILM-COATED TABLETS
Vasoprotectives and veinotonics.
Flavonoica 500 mg micronized purified fraction consisting of dios 50 mg 450 mg hesperidin flavonoids expressed in mina.
Sodium starch glycolate, microcrystalline cellulose, gelatin, hypromellose, sodium lauryl sulphate, glice rina, yellow iron oxide E172, red iron and ssido or 172, titanium dioxide, macrogol 6000, magnesium stearate, talc.
Symptoms attributable to venous insufficiency; States of frailty capil lare.
Hypersensitivity to the active substance or any of the eccipien you listed.
2 tablets per day (1 to noon and 1 to ser a) at mealtime, even in orroidario em Plexus venous insufficiency.
This medicine does not require any particular for co nservazione.
Interaction studies have not been conducted.
The following effects or adverse reactions have been reported and are classified according to the following frequency stat: very common (> = 1/10); c common (> = 1/100, 1 </10); uncommon (> = 1/1,000, 1 </100); rare (1/00, < 10.0 > = 1/1,000); very rare (< 1/10,000), not known.
Nervous system disorders.
Rare: dizziness, headache, malaise.
Gastrointesti NAL pathologies.
Common: diarrhoea, dyspepsia, nausea, vomiting; uncommon: colitis; not known: abdominal pain.
Skin and subcutaneous tissue disorders .. utaneo.
Rare: rash, pruritus, urticaria; not known: edema of the face, lips, eyelid; Quincke's oedema.
Emolin fopoietico system disorders.
Not known: thrombocytopenia.
The reporting of suspected adverse reactions that occur after authorisation of medicinal and it is important, as it allows a continuous monitoring of the risk-benefit balance of the medicinal product rto rappo.
PREGNANCY AND LACTATION:
Medication safety in pregnancy has not been determined, Pandey nto don't administer the product during pregnancy.
In the absence of data on excretion in breast milk, the treatment must be avoided during breastfeeding.